Tubeless Glucose Delivery System Found Safe and Effective
The device stabilizes glycated hemoglobin levels among adults and children with type 1 diabetes, according to a report.
Treatments
Type 2 Diabetes Frailty Index Predicts Poor Outcomes: BP and Glucose Interventions Can Mitigate Them
The researchers’ goal was to develop a frailty index and explore the relationship of frailty to subsequent adverse outcomes among participants with type 2 diabetes in the ADVANCE trial.
In Pediatric Type 1 Diabetes, Continuous SQ Insulin Infusions Do Not Lower HbA1c More Than MDI
Study authors conducted a retrospective cohort study to compare CSII and MDI treatments on metabolic control, body mass index, and prevalence of severe hypoglycemia in children.
Digital Intervention Improves Depression With Comorbid Hypertension, Diabetes Over Short Term
The researchers studied the effectiveness of a digital intervention in reducing depressive symptoms among patients with diabetes and/or hypertension.
Obesity Linked to Higher Rates of Beta-Lactam Treatment Failure, Longer Hospitalization for Infection
Researchers studied if patients with obesity who received a beta-lactam (BL) treatment had worse clinical outcomes compared to patients without obesity.
Placement on New ISF-Based Scales Helps Achieve Blood Glucose Targets
This retrospective cohort study assessed hospitalized patients with diabetes to see if the new ISF-based scales improved glycemic control vs a traditional single sliding scale.
Lowering LDL-C May Prevent Cardiovascular Disease in Asymptomatic Atherosclerosis
Researchers investigate whether asymptomatic atherosclerotic CVD can be prevented with an aggressive medical treatment that reduces LDL cholesterol to <60 mg/dl.
Thyroxine Replacement Therapy Reduces Hypothyroidism-Linked Pneumonia Risk
Researchers sought to evaluate the relationship between hypothyroidism and the risk of developing pneumonia.
Dasiglucagon Rapidly Restores Plasma Glucose in Children With Insulin-Induced Hypoglycemia
The researchers’ objective was to evaluate the safety and efficacy of dasiglucagon in patients aged 6 to 17 years with type 1 diabetes.
Study Finds Small Association Between Type 2 Diabetes Drugs and COVID-19-Related Mortality
The researchers investigated whether there are associations between different classes of glucose-lowering drugs and risk of COVID-19-related mortality in people with type 2 diabetes.
- Loading...
Loading...
Next post in Type 2 Diabetes
Loading... 
Loading...